The Following Documents Were Submitted by Members of the Public Prior To, and at the October 1, 2019 Marathon County Board of Health Meeting

Total Page:16

File Type:pdf, Size:1020Kb

The Following Documents Were Submitted by Members of the Public Prior To, and at the October 1, 2019 Marathon County Board of Health Meeting The following documents were submitted by members of the public prior to, and at the October 1, 2019 Marathon County Board of Health meeting. 13 Reasons Why You Should Question Vaccines: #1. Untested with normal scientific methods. Vaccines are untested by scientific methods that are the accepted methods in all other areas of science. The studies have not been done against unvaccinated populations, but only testing results between people getting one vaccine and people getting another. Accepted scientific research is done with double blind studies comparing those who do use a drug and those who do not. #2. Studies Done by Those who Profit from Vaccines Vaccines are tested and studied by the corporations that stand to profit from the vaccines. The profits are going to be billions of dollars at this time. This is like having the fox guard the hen house holding his knife and fork. Testing has never been done outside of these corporations that has been considered when giving approval. So why should we trust it? #3. Conflict of Interest in Studies Done Those who do studies in corporations about specific ingredients whether it's pharmaceuticals or Monsanto or any other corporate giant, are given jobs in the alphabet agencies (CDC, FDA, EPA and USDA) and given the job to approve the very thing they did the study on. Can you spell conflict of interest? The last head of the FDA was an exec from Monsanto and the current head of the FDA is from the pharmaceutical companies. Julie Gerberding, the former head of the CDC when the fraud was committed about the MMR, left the CDC for a cushy job at Merck in the vaccine division. How safe does that make you feel about your food and your drugs and vaccines? There should be rules forbidding anyone from moving from a company to the alphabet agency or back again, ever, but at least for 10 years or some large number. The woman at Monsanto who did a study on the growth hormone given to cows rBgH, went to the FDA and got a job and is the one who approved it as safe. Where was the independent testing? None done and there is none done in the pharmaceutical and vaccine industry either. #4. No long term studies or studies on the vaccine schedule ever There has been no long term study done ever on vaccines and the ingredients in them, or the large number of vaccines given. It took 50 years and scientific advancements in DNA testing to know that the retroviruses in the Polio vaccine had changed the human genome and were causing havoc. #5. Foreign DNA and Cell Fragments in Vaccines There have been no studies done on the insertion of foreign DNA in vaccines. Monkey, pig, insect, dog, bird and human DNA are all ingredients. Dr Paul Offit, the darling of the vaccine industry owned a patent on Rotateq which is a vaccine for Rotavirus. He made a profit of $40 million dollars on its sale. A 2010 study published in Journal of Virology revealed that his multi-million dollar grossing patent on the Rotateq vaccine contains a live simian retrovirus (with a 96% match of certainty) that has likely infected millions of children over the past few years with a virus that causes great harm. Retrovirus infections are permanent, and can carry on indefinitely into future generations. In other words, once they are inserted into the human genome they cannot be removed. Foreign DNA is changing the human genome. Corporations are playing god for profit. This is definitely not ok. Here is Dr Teresa Deisher, a world renowned geneticist on the subject. https://www.youtube.com/watch?v=H4A- vEfaPKI&t=1432s What is Coming through the needle- Contamination in foreign DNA http://www.rense.com/general32/thrur.htm Deep Sequencing Reveals Viral Vaccine Contaminants http://www.virology.ws/2010/03/29/deep-sequencing-reveals-viral- vaccine-contaminants/ http://www.greenmedinfo.com/sites/default/files/pdf/ML- Hewitson_2014_Advances_in_Virology.pdf #6. Ingredients or Adjuvants The things in vaccines are deadly and there is lots of information on those adjuvants or in another word ingredients, online everywhere from published journals, to Wikipedia, to OSHA and a host of other places. Thank God this is the information age. Some possible adjuvants are: aluminum (considered a neurotoxin), formaldehyde (embalming fluid. Remember biology class and the jars on the shelf with little pigs and frogs being preserved?), Thimerosal (mercury and it has been removed from some vaccines but is still in the flu and HIB and in trace amounts in almost all vaccines), Polysorbate 80 (linked to sterility), Phenoxyethanol (apreservative used in the cosmetic industry), Glutaraldehyde (acleaning fluid used to clean oil and gas pipelines and hospital equipment), and the list goes on. Look up the ingredients on the CDC Website : http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/b/excipient-table- 2.pdf A Glimpse Into the World of Vaccine Adjuvants http://vaccinechoicecanada.com/vacc... #7. Vaccines are being pedaled to pregnant women. There have been NO studies done on fetal development and vaccines. The package inserts of all these vaccines say that specifically. In fact there are a few studies that show a rise of fetal deaths through spontaneous abortion: 16.7% with the DTaP, and in a 3 year period of the flu season, there was a 4000% rise due to vaccinations. We warn women to eat a clean diet and then want to inject them with neuro toxins and foreign DNA which crosses the placenta into their precious babies. Dr. Suzanne Humphries talks about what is wrong with the study about flu shots for pregnant women. http://www.vaccinationcouncil.org/2012/02/29/3013/ DTaP causes 16.7% miscarriage rate http://www.ncbi.nlm.nih.gov/pubmed/22727350 Fluvaccine and 4000% increase in miscarriage http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888271/ #8 The vaccine companies cannot be sued for injuries or deaths. The National Childhood Vaccine Injury Act of 1986 was passed by congress after the vaccine manufacturers: Merck, Wyeth, Lederle, and Connaught threatened to stop making vaccines altogether in the United States. So the law was passed that they can't be sued. Instead a Vaccine Injury Court was set up and a portion from each vaccine (which you pay for), goes to pay for payouts through that court for injuries and deaths. Only about 10% of injuries make it there. Until there is liability, like there is in every other drug on the market, then all the vaccines are suspect. The vaccine court has paid out over$3 billion in damages. It is also holding on to much money that should go to families. It is interesting to note that there are 290 or more new vaccines in the works, including those for acne, high blood pressure, cholesterol, cancer and more. Manufacturers are moving away from drugs and to vaccines because they cannot be sued. Imagine the long lines for the blood pressure vaccine and people start to realize they have developed an autoimmune disorder or asthma or GBS. Imagine when they find out there is no liability. No more bad drug ads. It's a win win for the Pharmaceutical companies and a bad thing for the rest of us. Childhood Injury Act of 1986 http://www.nvic.org/injury-compensa... #9. Doctors receive bonuses at the end of the year from the pharmaceutical companies for the number of patients they have who are vaccinated. This does not stop with bonuses. If a certain number are not vaccinated the insurance company can drop a doctor. A Pediatrician Lays Out the Dollars for you https://www.facebook.com/knowthevax... #10. Whistleblower at the CDC has come forward and given as many as 10,000 documents to congress from the CDC about the link that was suppressed between the MMR and autism.This is just the tip of the iceberg. The lead developer of Gardasil has come forward to say that the vaccine is unnecessary. How many more just haven't spoken out? Corruption, lying, deception being practiced all in the name of profit. The pro vaccine crowd and your doctor's office will say this is debunked, but 100,000 documents say otherwise. We Destroyed Documents Showing the MMR Caused Autism https://sharylattkisson.com/cdc-sci… Congressman Bill Posey addressing the congress- August 2015 https://www.youtube.com/watch?v=jGRjn_gIJw0 #11.The CDC owns the patents to vaccines. The CDC owns patents to Ebola, some Influenza strains, and who knows what else. They make a profit on the disease. If there is a pandemic they can make billions. Why should the government make a profit on sickness? That is just suspect and another reason not to trust what they are doing. CDC List of Patents Owned https://steemit.com/vaccines/@canadian-coconut/patents-that-cdc-owns-for-vaccines- conflict-of-interest-biased-towards-profit-and-not-public-health #12. Doctors and Nurses are not educated on what is in vaccine or reactions. It is apparent that most doctors and nurses giving vaccinations don't read the package inserts, don't study what is in the vaccines and really are not well read about them. They have not read the toxicology of the adjuvants in the vaccines (the extra stuff in them like chemicals and foreign DNA). They tell a pregnant women not to eat too much fish because of mercury, yet try to get her to take a flu shot which has mercury in it. Those we should be able to trust are not trustworthy. When parents call after their child receives a vaccine, because the child is having seizures or has other problems, they are told it's normal.
Recommended publications
  • Feb 2020 February Is Cabin Fever Month
    Like Share Tweet Share this Page: Anthroposophic Medicine for Whole Person Healing & Wellness February, 2020 February is cabin fever month where winter has a strong hold. In Sacramento, it’s spring-like. We will be closed Friday, February 14. Smile, and generously use loving words, and maybe fewer hugs this germy Valentine’s! (See #3 under Coronavirus and watch 'sanitation.') Remember to have your ANNUAL check-in! Stay established with RMT so we are up- to-date if you need help in the time ahead. Our doctor-patient relationship with you is the foundation of your medical exemption – gaps in contact over a year make it look like we do not have an active doctor-patient relationship. Get in front of the calendar and get it done! Combine that with a needed sports physical or vaccine consult to plan the schedule for the safest vaccination possible. Read below about: CORONALikeVIRUS, Share Tweet Share this Page: What to do if you receive a letter from the DEPARTMENT OF INVESTIGATION , Updates on positive movement in LEGISLATION, and REACTIONS TO CALM POWDER. Also, a great free FERMENTATION SUMMIT is underway now-- join! ❤ A Voice for Choice LiveAware Expo is this month!❤ Check out the speakers, including Elana Freeland, author of Under an Ionized Sky: from chemtrails to space fence lockdown. Peaceful days MKS for all of us CORONAVIRUS 1. Prevention: Vit C, Vit A (Carlson cod liver oil), Zinc, Astragalus (if you have autoimmune disease) or Elderberry (for those without autoimmune disease); glycyrrhiza (licorice) helps treat symptoms. (We have high quality versions of these immune strengthening products for you to purchase.) Watch more on this HERE.
    [Show full text]
  • Plant Molecular Farming: a Viable Platform for Recombinant Biopharmaceutical Production
    plants Review Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production Balamurugan Shanmugaraj 1,2, Christine Joy I. Bulaon 2 and Waranyoo Phoolcharoen 1,2,* 1 Research Unit for Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok 10330, Thailand; [email protected] 2 Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences Chulalongkorn University, Bangkok 10330, Thailand; [email protected] * Correspondence: [email protected]; Tel.: +66-2-218-8359; Fax: +66-2-218-8357 Received: 1 May 2020; Accepted: 30 June 2020; Published: 4 July 2020 Abstract: The demand for recombinant proteins in terms of quality, quantity, and diversity is increasing steadily, which is attracting global attention for the development of new recombinant protein production technologies and the engineering of conventional established expression systems based on bacteria or mammalian cell cultures. Since the advancements of plant genetic engineering in the 1980s, plants have been used for the production of economically valuable, biologically active non-native proteins or biopharmaceuticals, the concept termed as plant molecular farming (PMF). PMF is considered as a cost-effective technology that has grown and advanced tremendously over the past two decades. The development and improvement of the transient expression system has significantly reduced the protein production timeline and greatly improved the protein yield in plants. The major factors that drive the plant-based platform towards potential competitors for the conventional expression system are cost-effectiveness, scalability, flexibility, versatility, and robustness of the system. Many biopharmaceuticals including recombinant vaccine antigens, monoclonal antibodies, and other commercially viable proteins are produced in plants, some of which are in the pre-clinical and clinical pipeline.
    [Show full text]
  • US EPA, Pesticide Product Label, WIDESTRIKE 3 INSECT
    UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 OFFICE OF CHEMICAL SAFETY AND POLLUTION PREVENTION October 18, 2016 Stephanie L. Burton US Regulatory Manager Dow AgroSciences LLC 9330 Zionsville Road Indianapolis, IN 46268-1054 Subject: PRIA (Pesticide Registration Improvement Act) Amendment – to update the terms of registration related to gene flow and revise the product label. Product Name: WideStrike® 3 Insect Resistant Cotton EPA Registration Number: 68467-19 Application Date: June 23, 2016 OPP Decision Number: 518794 Dear Ms. Burton: The amendment referred to above, submitted in connection with registration under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended, are acceptable provided you comply with the revised terms of registration as set forth below: 1. Submit/cite all data required for registration of your product under FIFRA § 3(c)(5) when the Agency requires all registrants of similar products to submit such data. 2. Gene Flow The following information regarding commercial production must be included in the grower guide for WideStrike® 3 Insect Resistant Cotton: a) No planting of WideStrike® 3 Insect Resistant Cotton is permitted south of Route 60 (near Tampa) in Florida. b) Commercial culture of WideStrike® 3 Insect Resistant Cotton is prohibited in Hawaii, Puerto Rico, and the US Virgin Islands. The following information regarding test plots and seed production must appear in contracts or on bags of WideStrike® 3 Insect Resistant Cotton intended for the following purposes: Page 2 of 10 EPA Reg. No. 68467-19 OPP Decision No. 518794 a) Test plots or breeding nurseries, regardless of the plot size, established in Hawaii must not be planted within 3 miles of Gossypium tomentosum.
    [Show full text]
  • Monsanto Company in Microsoft Word Format Together with a Copy of the Transmittal Letter That Accompanies the Filing of Two Paper Copies of the Submission
    From: Letzler, Kenneth [mailto:[email protected]] Sent: Thursday, December 31, 2009 1:03 PM To: ATR-Agricultural Workshops Subject: Comment Attached please find a comment submitted on behalf of Monsanto Company in Microsoft Word format together with a copy of the transmittal letter that accompanies the filing of two paper copies of the submission. _____________________________ U.S. Treasury Circular 230 Notice Any U.S. federal tax advice included in this communication (including any attachments) was not intended or written to be used, and cannot be used, for the purpose of (i) avoiding U.S. federal tax-related penalties or (ii) promoting, marketing or recommending to another party any tax-related matter addressed herein. _____________________________ This communication may contain information that is legally privileged, confidential or exempt from disclosure. If you are not the intended recipient, please note that any dissemination, distribution, or copying of this communication is strictly prohibited. Anyone who receives this message in error should notify the sender immediately by telephone or by return e-mail and delete it from his or her computer. ---------------------------------------------------------------------- For more information about Arnold & Porter LLP, click here: http://www.arnoldporter.com Competition and Innovation in American Agriculture A Response to the American Antitrust Institute’s “Transgenic Seed Platforms: Competition Between a Rock and a Hard Place?” Submitted on Behalf of Monsanto Company In Response to the Request for Comments by the United States Department of Agriculture and United States Department of Justice, Antitrust Division, in Connection with Their Hearings on “Agriculture and Antitrust Enforcement Issues in Our 21st Century Economy” Vandy Howell, Ph.D.
    [Show full text]
  • Dow Agrosciences
    Dow AgroSciences LLC (Dow AgroSciences) markets crop protection Dow AgroSciences products and seeds for a broad spectrum of crops, including maize, soybean, cotton and forage. The company began in the 1950s as the agricultural unit of The Dow Chemical Company. As a joint venture Corporate Data of The Dow Chemical Company and Eli Lilly & Co., it was known as Headquarters: Indianapolis, Indiana, USA DowElanco from 1989 onwards. In 1997, The Dow Chemical Company Ownership type: Listed Group revenue (2014): USD 729,000,0000 acquired 100% ownership.* Global Index – Commitment Performance Transparency Innovation Field Crop Seed Companies 1.27 1.46 2.05 0.25 Dow AgroSciences ranks in the lower 5 range of the Global Index of Field Crop Seed Companies. It has clear rank out of 7 approaches to Public Policy & Stakeholder A Governance & 1.13 score 1.38 Engagement and existing breeding Strategy B Public Policy & 2.68 programs for resistance to pests and Stakeholder Engagement diseases, abiotic stress tolerance and C Genetic Resources & 1.09 Intellectual Property yield, although it is not clear to what extent these programs D Research & 1.31 specifically target the development of varieties suitable for Development E Marketing & 1.11 Index countries and smallholder farmers. Seed sales were Sales found only in Latin American Index countries. Given the F Capacity 2.08 indications of research and capacity-building activities rel- Building G Local Seed Sector 0.91 evant for improved access to seeds for smallholder farmers in Advancement other regions, the company is encouraged to develop its seed 0 1 2 3 4 5 business serving smallholder farmers on a more global scale.
    [Show full text]
  • Discrimination and Harassment
    Dear Member of the Legislature - My name is April Groom and I am in District 54. I am a mom of a child with multiple food allergies and sensitivities and I’m concerned that if this bill passes, it will be extremely hard to get a medical exemption. I’m also concerned because my son is on an IEP. Per the law of his IEP, I believe this would be discrimination and harassment. Please oppose HB 3063. Pease read the attached letter from my 9-year-old, from District 54, who's goal it is in school this year to Be a Better writer! He has an IEP. This letter was a 2-day labor of love. We are concerned he would Be denied a puBlic education if this Bill passes and per his IEP, we feel he would Be discriminated against. His letter is attached in this email and it is also copied here fully (he got tired of writing and shortened it), included in my first point of concern, Below titled: Civil Rights/Discrimination. HB 3063 is an infringement on our right to bodily autonomy and informed consent. The US Supreme Court has ruled vaccines as 'unavoidably unsafe' and where there is risk, there must Be choice. Each and every vaccine insert for each and every vaccine lists "Death" as a possible outcome. See my 8 points of concern, listed numerically, with supporting factors, below: As a mom and a citizen of the state of Oregon, and we as parents, I am concerned aBout the following 8 points, regarding HB3063: 1).Civil Rights/ Discrimination 2).
    [Show full text]
  • Dow Agrosciences Petitions (09-233- 01P, 09-349-01P, and 11-234-01P) for Determinations of Nonregulated Status for 2,4-D-Resistant Corn and Soybean Varieties
    Dow AgroSciences Petitions (09-233- 01p, 09-349-01p, and 11-234-01p) for Determinations of Nonregulated Status for 2,4-D-Resistant Corn and Soybean Varieties Draft Environmental Impact Statement—2013 Agency Contact: Sid Abel Biotechnology Regulatory Services 4700 River Road USDA, APHIS Riverdale, MD 20737 Fax: (301) 734-6352 The U.S. Department of Agriculture (USDA) prohibits discrimination in all its programs and activities on the basis of race, color, national origin, sex, religion, age, disability, political beliefs, sexual orientation, or marital or family status. (Not all prohibited bases apply to all programs.) Persons with disabilities who require alternative means for communication of program information (Braille, large print, audiotape, etc.) should contact USDA’S TARGET Center at (202) 720–2600 (voice and TDD). To file a complaint of discrimination, write USDA, Director, Office of Civil Rights, Room 326–W, Whitten Building, 1400 Independence Avenue, SW, Washington, DC 20250–9410 or call (202) 720–5964 (voice and TDD). USDA is an equal opportunity provider and employer. Mention of companies or commercial products in this report does not imply recommendation or endorsement by the U.S. Department of Agriculture over others not mentioned. USDA neither guarantees nor warrants the standard of any product mentioned. Product names are mentioned solely to report factually on available data and to provide specific information. This publication reports research involving pesticides. All uses of pesticides must be registered by appropriate State and/or Federal agencies before they can be recommended. CAUTION: Pesticides can be injurious to humans, domestic animals, desirable plants, and fish and other wildlife—if they are not handled or applied properly.
    [Show full text]
  • Department of Entomology Newsletter for Alumni and Friends (2011) Iowa State University, Department of Entomology
    Department of Entomology Newsletter Entomology 1-2011 Department of Entomology Newsletter For Alumni and Friends (2011) Iowa State University, Department of Entomology Follow this and additional works at: http://lib.dr.iastate.edu/entnewsletter Part of the Entomology Commons Recommended Citation Iowa State University, Department of Entomology, "Department of Entomology Newsletter For Alumni and Friends (2011)" (2011). Department of Entomology Newsletter. 5. http://lib.dr.iastate.edu/entnewsletter/5 This Book is brought to you for free and open access by the Entomology at Iowa State University Digital Repository. It has been accepted for inclusion in Department of Entomology Newsletter by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Sample January 2011 Newsletter For Alumni and Friends Les Lewis Retires At this writing my retirement is fast approach- ing. I always thought I would retire from my job as Research Leader and Scientist with the USDA- ARS. But things changed when Dean Wintersteen gave me the opportunity to be Chair of Entomol- ogy in the Fall of 2008 for a two-year appoint- ment. As I review my career, the common thread that runs throughout is the privilege of always being surrounded by persons that enjoyed their jobs and wanted to succeed. It has made my career enjoyable and rewarding. As I finish this appointment and decide what to do next, like many who have retired before me, I have a few things to finish from the laboratory. One scien- tific matter that I will pursue is the description of a microsporidium isolated from the western bean cutworm, Striacosta albicosta, an insect Donald Lewis presents Les Lewis with a retirement gift from the department at the holiday party in December.
    [Show full text]
  • Refuge Advanced®
    Agronomy Profi le Refuge Advanced® Overview With so many trait options, following refuge management guidelines has become more complicated. SmartStax® Refuge Advanced® makes refuge management easier by ensuring refuge compliance in the Corn Belt1 with a blend of 95% SmartStax seeds and 5% non-insect-traited refuge seeds in one bag. What you should know • Refuge Advanced is a convenient single-bag solution with no separate refuge required in the Corn Belt1. • Acres planted with SmartStax Refuge Advanced protect Bt technology by With Refuge Advanced, refuge hybrids are distributed allowing Bt-susceptible insects to feed and breed with potentially resistant throughout the field along with SmartStax hybrids, ensuring refuge compliance in the Corn Belt.1 insects of the same type, thus helping to prevent resistance. • Refuge Advanced reduces the number of steps growers need to take to maximize whole-farm yield potential, makes planning easier, and simplifies record-keeping for farm management and compliance reporting. 30-Second Action steps SEC Summary 1. Select hybrids: Select the best genetics that meet the agronomic needs of • SmartStax Refuge Advanced is a your fields, combined with the best trait package to maximize yield potential single-bag solution that simplifies and protect against yield-robbing insects. With Refuge Advanced, there is no refuge management in the Corn Belt.1 need to purchase additional refuge hybrids. • SmartStax Refuge Advanced combines 2. Consider agronomic factors: A proprietary blending process ensures even Bt-traited insect control with refuge distribution of refuge seed and SmartStax seed in the field. The refuge seed, to protect Bt traits and reduce component is subject to the same high-quality standards as SmartStax development of resistance.
    [Show full text]
  • Guide to Biotechnology 2008
    guide to biotechnology 2008 research & development health bioethics innovate industrial & environmental food & agriculture biodefense Biotechnology Industry Organization 1201 Maryland Avenue, SW imagine Suite 900 Washington, DC 20024 intellectual property 202.962.9200 (phone) 202.488.6301 (fax) bio.org inform bio.org The Guide to Biotechnology is compiled by the Biotechnology Industry Organization (BIO) Editors Roxanna Guilford-Blake Debbie Strickland Contributors BIO Staff table of Contents Biotechnology: A Collection of Technologies 1 Regenerative Medicine ................................................. 36 What Is Biotechnology? .................................................. 1 Vaccines ....................................................................... 37 Cells and Biological Molecules ........................................ 1 Plant-Made Pharmaceuticals ........................................ 37 Therapeutic Development Overview .............................. 38 Biotechnology Industry Facts 2 Market Capitalization, 1994–2006 .................................. 3 Agricultural Production Applications 41 U.S. Biotech Industry Statistics: 1995–2006 ................... 3 Crop Biotechnology ...................................................... 41 U.S. Public Companies by Region, 2006 ........................ 4 Forest Biotechnology .................................................... 44 Total Financing, 1998–2007 (in billions of U.S. dollars) .... 4 Animal Biotechnology ................................................... 45 Biotech
    [Show full text]
  • Genetically Modified Organism (GMO) Labeling in the U.S
    Genetically Modified Organism (GMO) Labeling in the U.S. Alicia S. Añino3 Abstract: To label Genetically Modified Organisms (GMOs) or treat them equally with non- genetically modified foods without labeling is a contentious issue, not only in the United States, but around the world, and has been ever since these engineered foods were introduced in the late 20th century (Huffman, 2004). This article seeks to objectively look at the issues from those that want to label GMOs and from those that are against it; as well as offer suggestions for moving forward to satisfy parties on both sides of the issue. 3 Alicia is a graduate student in SPEA's MPA urban sustainability program. She is a native Hoosier, earning her undergraduate degree in business from IU and a certificate in translation studies from IUPUI. She is also currently the Communication Chair for Peace Corps Panama Friends, where she is editor of the quarterly e-newsletter, El Bochinche. Alicia works full-time in the IUPUI University Library as an administrative assistant and is a freelance translator working on projects for Professor Garfield, Social Security Administration, Spanish for Dummies series, and more. 32 To label Genetically Modified Organisms (GMO/GMOs) or treat them equally with non- genetically modified foods without labeling is a contentious issue, not only in the United States, but around the world, and has been ever since these engineered foods were introduced in the late 20th century (Huffman, 2004). There are vociferous voices from public consumers about separating and labeling GMOs for safety, consumer knowledge, and individual choice reasoning; with equally vocal opinions from the agricultural industry about the expensiveness and futility of labeling.
    [Show full text]
  • Genetically Engineered Trees the New Frontier of Biotechnology
    GENETICALLY ENGINEERED TREES THE NEW FRONTIER OF BIOTECHNOLOGY NOVEMBER 2013 CENTER FOR FOOD SAFETY | GE TREES: THE NEW FRONTIER OF BIOTECHNOLOGY Editor and Executive Summary: DEBBIE BARKER Writers: DEBBIE BARKER, SAM COHEN, GEORGE KIMBRELL, SHARON PERRONE, AND ABIGAIL SEILER Contributing Writer: GABRIELA STEIER Copy Editing: SHARON PERRONE Additonal Copy Editors: SAM COHEN, ABIGAIL SEILER AND SARAH STEVENS Researchers: DEBBIE BARKER, SAM COHEN, GEORGE KIMBRELL, AND SHARON PERRONE Additional Research: ABIGAIL SEILER Science Consultant: MARTHA CROUCH Graphic Design: DANIELA SKLAN | HUMMINGBIRD DESIGN STUDIO Report Advisor: ANDREW KIMBRELL ACKNOWLEDGEMENTS We are grateful to Ceres Trust for its generous support of this publication and other project initiatives. ABOUT US THE CENTER FOR FOOD SAFETY (CFS) is a national non-profit organization working to protect human health and the environment by challenging the use of harmful food production technologies and by promoting organic and other forms of sustainable agriculture. CFS uses groundbreaking legal and policy initiatives, market pressure, and grassroots campaigns to protect our food, our farms, and our environment. CFS is the leading organization fighting genetically engineered (GE) crops in the US, and our successful legal chal - lenges and campaigns have halted or curbed numerous GE crops. CFS’s US Supreme Court successes include playing an historic role in the landmark US Supreme Court Massachusetts v. EPA decision mandating that the EPA reg - ulate greenhouse gases. In addition, in
    [Show full text]